Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Antidiabetic Potential of Amritarishta Prepared by Traditional and Modern Methods in Alloxan Induced Diabetic Rats


Affiliations
1 Department of Pharmacognosy, Dr. K. N. Modi Institute of Pharmaceutical Education and Research, Modinagar, Uttar Pradesh, India
     

   Subscribe/Renew Journal


The objective of the present study was to evaluate the effect of Amritarishta-T and Amritarishta-M prepared by traditional and modern methods respectively and marketed Amritarishta on fasting blood glucose and serum lipid profile in alloxan induced diabetic rats. Oral administration of Amritarishta-T, Amritarishta-M and marketed Amritarishta ( 2 ml/kg p.o.) for 21 days caused a significant decrease in fasting blood glucose (FBG) and showed significant rise in blood glutathione level (GSH) in diabetic rats. Glibenclamide was used as a standard antidiabetic drug (10 mg/kg, p.o). These preparations also caused significant reduction in serum cholesterol, LDL and triglycerides and showed significant rise in serum HDL level in diabetic albino rats. Thus all these preparations were able to maintain the tested parameters near to the normal level significantly.

Keywords

Cardiovascular Risk, Blood Glucose, Anti-Diabetic, Glutathione, Lipid Profile, Amritarishta, Alloxan.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H , Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Met 2000; 85:2970-2973.

  • Pickup JC, William G. Epidemiology of Diabetes mellitus. In Textbook of Diabetes. vol.I, 2nd ed. Blackwell, Oxford; 1997. p. 3.1-3.28.

  • Sagara M, Satoh J, Wada R, Yagihashi S, Takahashi K, Fukuzawa M, Muto G, MutoY , Toyota T. Inhibition of development of peripheral neuropathy in STZ-induced diabetic rats with N-acetylcysteine. Diabetologia 1996; 53:446-449.

  • Kesari AN, Gupta RK, Watal G. Hypoglycemic effects of Murraya koenigii on normal and alloxan diabetic rabbits. J Ethnopharmacol 2005; 97: 247-251.

  • Davidson MB. Diabetes mellitus Diagnosis and treatment. New York: Wiley; 1981. p. 27-48.

  • The Ayurvedic Formulary of India, Part-I. 2000, 1st edition, The Controller of Publications, Delhi, 6.

  • Kumar S, Verma NS, Pande D and Srivastava PS. In vitro regeneration and screening of berberinein Tinospora cordifolia. Journal of Medicinal and Aromatic Plant Science 2000;22:61.

  • Biset NG and Nwaiwu J.Quaternary alkaloids of Tinospora species. Planta Medica 1983;48:275-9.

  • Maurya R, Wazir V, Tyagi A and Kapil RS. Cordifoliosides A and B, two new phenylpropene disaccharides from Tinospora cordifolia possessing immunostimulant activity. Natural Product Letter 1996;8:7-10.

  • Gangan VD, Pradhan P, Sipahimalani AT and Banerji A. Cordifoliosides A, B,C:Norditerpene furan glycosides from Tinospora cordifolia. Phytochemistry 1994;37:781-6.

  • Dixit SN and Khosa RL. Chemical investigation of Tinospora cordifolia. Indian Journal of Applied Chemistry 1971;34:46-7.

  • Maurya R and Handa SS. Tinocordifolin, a sesquiterpene from Tinospora cirdifolia. Phytochemistry 1998;49:1343-6.

  • Kidwai AR, Salooja KC, Sharma VN, Siddiqui S. Chemical examination of Tinospora cordifolia. Journal of Science and Indian Research 1949; 8:115-8.

  • Stanely M, Prince P and Menon VP. Antioxidant action of Tinospora cordifolia ischolar_main extract in alloxan diabetic rats.Phytotherapy Research 2001;15:213-8.

  • Mehrotra R, Katiyar CK and Gupta AP. Hepatoprotective compositions and composition for treatment of conditions related to hepatitis-B and E infection. US Patent 749296. 2000.

  • Prince PS and Menon VP. Antioxidant activity of Tinospora cordifolia ischolar_mains in experimental diabetes. Journal of Ethnopharmacology 1999;65:277-81.

  • Ikram M, Khattak SG and Gilani SN. Antipyretic studieson some indigenous Pakistani medicinal plants. Journal of Ethnopharmacology 1987;19:185-92.

  • Manjrekar PN, Jolly CI and Narayanan S. Comparative studies of immunomodulatory activity of Tinospora cordifolia and Tinospora sinensis. Fitoterapia 2000;71:254-7.

  • Jagetia GC, Nayak V and Vidyasagar MS. Evaluation of the antineoplastic activity of guduchi (Tinospora cordifolia) in cultured HeLa cells. Cancer Letter 1998;127:71-82.

  • Mishra S. Bhaisazya Kalpana Vigyan. Varanasi, India: Chaukambha Surbharati Prakashan; 2005.p. 253-254.

  • Alam M, Radhamani S, Ali U and Purushottam KK. Microbiological Screening of Dhataki flowers. Journal of Research in Ayurveda and Siddha 1984; 2(4):371-375.

  • Nishikant AR, Naresh JG. Antidiabetic Activity of hydroethanolic extract of Cyperus rotundus in alloxan induced Diabetes in rats. Fitoterapia 2006; 77:585-588.

  • Sharma SR, Dwivedi SK, Swarup D. Hypoglycemic and hypolipidemic effects of Cinnamomum tamala Nees leaves. Indian J Exp Biol 1996; 34:372-374.

  • Giordano BP, Thrash W, Hollenbaugh L, Dube WP, Hodges C, Swain A, Banion CR , Klingensmith GJ. Performance of seven blood glucose testing systems at high altitude. Diabet Educa 1989; 15: 444-448.

  • Allain CC, Poon LS, Chan CS, Richmond W. Enzymatic Determination of Total Serum cholesterol. Clin Chem 1974; 20: 471-475.

  • Muller PH, Schmulling RM, Liebich HM, Eggstein M. A fully Enzymatic Triglyceride Determination. J Clin Chem 1977; 15: 457-464.

  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.

  • Bowers LD. Kinetic Serum Creatinine Assay. The role of various factors in determining specificity. Clin Chem 1980; 26: 551-554.

  • Wilson BW. Automatic Estimation of urea using urease and alkaline phenol. Clin Chem 1966; 12: 360-368.

  • Sasaki MA. New method for the determination of serum alkaline phosphatase. Use of Berthelot's reaction for the estimation of phenol released by enzymatic activity. Igaku To Seibutsugaku 1966; 70: 208-214.

  • Beutler E, Duron O, Kelly BM. Improved method for determination of blood glutathione. J Lab Med 1963; 61:882-888.

  • Proks P, Reimann F, Gribble F. Sulfonyl urea stimulation in insulin secretion. Diabetes 2002; 51: S368-76.

  • Shankar PK, Kumar V, Rao N. Evaluation of Anti-diabetic activity of Ginkgo biloba in streptozotocin induced Diabetic Rats. Iranian J Pharmacol Therapeutics 2005; 4: 16-19.

  • Wohaleb SA, Godin DV. Alterations in free radical tissue defence mechanism in streptozotocin induced diabetes in rat. Diabetes 1987; 36: 1014-1018.

  • Mitra SK, Gopumadhvans, Muralidhar TS, Anturlikar SD, Sujatha MB. Effect of D-400, a mineraloherbal preparation on lipid profile, glycosylated haemoglobin and glucose tolerance in streptozotocin induced diabetic rats. Indian J Exp Biol 1995; 33: 798-800.

  • Bopanna KN, Kanna J, Sushma G, Balaram R, Rathod SP. Antidiabetic and antihyperlipidemic effects of neem seed kernel powder on alloxan diabetic rabbits. Indian J Pharmacol 1997; 29:162-7.

  • Cho SY, Park JY, Park EM. Alteration of hepatic antioxidant enzyme activities and lipid profile in streptozotocin induced diabetic rats by supplementation of dandelion water extract. Clin Chem Acta 2002; 317: 109-117.


Abstract Views: 349

PDF Views: 1




  • Antidiabetic Potential of Amritarishta Prepared by Traditional and Modern Methods in Alloxan Induced Diabetic Rats

Abstract Views: 349  |  PDF Views: 1

Authors

Preeti Tiwari
Department of Pharmacognosy, Dr. K. N. Modi Institute of Pharmaceutical Education and Research, Modinagar, Uttar Pradesh, India

Abstract


The objective of the present study was to evaluate the effect of Amritarishta-T and Amritarishta-M prepared by traditional and modern methods respectively and marketed Amritarishta on fasting blood glucose and serum lipid profile in alloxan induced diabetic rats. Oral administration of Amritarishta-T, Amritarishta-M and marketed Amritarishta ( 2 ml/kg p.o.) for 21 days caused a significant decrease in fasting blood glucose (FBG) and showed significant rise in blood glutathione level (GSH) in diabetic rats. Glibenclamide was used as a standard antidiabetic drug (10 mg/kg, p.o). These preparations also caused significant reduction in serum cholesterol, LDL and triglycerides and showed significant rise in serum HDL level in diabetic albino rats. Thus all these preparations were able to maintain the tested parameters near to the normal level significantly.

Keywords


Cardiovascular Risk, Blood Glucose, Anti-Diabetic, Glutathione, Lipid Profile, Amritarishta, Alloxan.

References